# SLIPPERS Reconsidered: Clinical, Radiological, and Pathological Overlap with PACNS—A Case Report

**Authors:** Inhar Esnaola Barriola, Celia Fernández Gonzalez, Teresa Cabada Giadas, María Victoria Zelaya Huerta, María Elena Erro Aguirre

PMC · DOI: 10.3390/reports9010047 · Reports - Clinical Practice and Surgical Cases · 2026-01-31

## TL;DR

This case report highlights the diagnostic challenges between SLIPPERS and PACNS, showing how two patients initially thought to have SLIPPERS were later diagnosed with PACNS.

## Contribution

The paper emphasizes the diagnostic overlap between SLIPPERS and PACNS and suggests that some SLIPPERS cases may be PACNS variants.

## Key findings

- Two patients initially diagnosed with SLIPPERS were later found to meet PACNS diagnostic criteria.
- Advanced MRI and histopathological analysis are crucial to differentiate between SLIPPERS and PACNS.
- Both patients responded to corticosteroids but required additional immunosuppressive therapy for long-term management.

## Abstract

Background and Clinical Significance: SLIPPERS syndrome (Supratentorial Lymphocytic Inflammation with Parenchymal Perivascular Enhancement Responsive to Steroids) was first described in 2015 as a variant of CLIPPERS restricted to supratentorial regions. Only a few cases have been reported so far, and its distinction from primary angiitis of the central nervous system (PACNS) remains challenging, as both may present with overlapping clinical, radiological, and histopathological features. We report two patients initially diagnosed with SLIPPERS but finally fulfilling the diagnostic criteria for PACNS, highlighting the complexity of the differential diagnosis. Case Presentation: The first patient was a 49-year-old woman who presented with seizures, memory impairment, and facial neuralgia. MRI showed multiple cortico-subcortical and deep nodular lesions in the left hemisphere with gadolinium enhancement. Brain biopsy revealed a T-cell-predominant lymphocytic vascular infiltrate. She responded to corticosteroids but later relapsed, requiring methotrexate for long-term immunosuppression, with no further recurrences during seven years of follow-up. The second patient was a 64-year-old man with hypertension, dyslipidemia, and alcohol use who developed repeated focal-to-generalized seizures. MRI disclosed multifocal nodular gadolinium-enhancing right hemispheric lesions, with SWI microhemorrhages. Biopsy demonstrated transmural T-cell vasculitic infiltrates. He responded to corticosteroids and methotrexate, but radiological progression at 14 months prompted replacement with cyclophosphamide. Conclusions: There is a considerable clinical, radiological, and histological overlap between SLIPPERS and PACNS. Careful analysis of advanced MRI sequences, particularly angiographic and vessel-wall imaging studies, combined with meticulous histopathological analysis, is essential to avoid misdiagnosis. These similarities suggest that some cases attributed to SLIPPERS may, in fact, correspond to variants of PACNS.

## Linked entities

- **Chemicals:** methotrexate (PubChem CID 4112), cyclophosphamide (PubChem CID 2907)
- **Diseases:** facial neuralgia (MONDO:0001818), dyslipidemia (MONDO:0002525)

## Full-text entities

- **Genes:** MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, BMPER (BMP binding endothelial regulator) [NCBI Gene 168667] {aka CRIM3, CV-2, CV2}, PSG2 (pregnancy specific beta-1-glycoprotein 2) [NCBI Gene 5670] {aka CEA, PSBG2, PSG1}, GAD2 (glutamate decarboxylase 2) [NCBI Gene 2572] {aka GAD65}, AMPH (amphiphysin) [NCBI Gene 273] {aka AMPH1}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, IGLON5 (IgLON family member 5) [NCBI Gene 402665], ZIC4 (Zic family zinc finger 4) [NCBI Gene 84107], PNMA2 (PNMA family member 2) [NCBI Gene 10687] {aka MA2, MM2, RGAG2}, SDC1 (syndecan 1) [NCBI Gene 6382] {aka CD138, SDC, SYND1, syndecan}, CNTNAP2 (contactin associated protein 2) [NCBI Gene 26047] {aka AUTS15, CASPR2, CDFE, NRXN4, PTHSL1}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, PNMA1 (PNMA family member 1) [NCBI Gene 9240] {aka MA1}, DPP6 (dipeptidyl peptidase like 6) [NCBI Gene 1804] {aka DPL1, DPPX, MRD33, VF2}, SOX1 (SRY-box transcription factor 1) [NCBI Gene 6656], DPYSL5 (dihydropyrimidinase like 5) [NCBI Gene 56896] {aka CRAM, CRMP-5, CRMP5, CV2, RTSC4, Ulip6}, CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}, NPEPPS (aminopeptidase puromycin sensitive) [NCBI Gene 9520] {aka AAP-S, MP100, PSA}, AFP (alpha fetoprotein) [NCBI Gene 174] {aka AFPD, FETA, HPAFP}, LGI1 (leucine rich glioma inactivated 1) [NCBI Gene 9211] {aka ADLTE, ADPAEF, ADPEAF, DEE121, EPITEMPIN, EPT}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, DNER (delta/notch like EGF repeat containing) [NCBI Gene 92737] {aka UNQ26, bet}
- **Diseases:** CMV (MESH:D003586), autoimmune (MESH:D001327), lesions (MESH:D009059), leptomeningeal malignancy (MESH:D008577), seizure (MESH:D012640), stenoses (MESH:D003251), neurological deficit (MESH:D009461), paraneoplastic (MESH:D010257), cerebral vasoconstriction syndrome (MESH:D002547), headache (MESH:D006261), SLIPPERS (MESH:D007249), injury to (MESH:D014947), inflammatory vasculitis (MESH:D014657), SLIPPERS syndrome (MESH:D013577), CLIPPERS (MESH:D015451), dyslipidemia (MESH:D050171), neoplastic (MESH:D009369), hemispheric lesions (MESH:D006832), ischemic (MESH:D002545), inflammatory syndrome (MESH:D018746), facial neuralgia (MESH:D005156), edema (MESH:D004487), lymphoproliferative disorders (MESH:D008232), lymphoma (MESH:D008223), necrosis (MESH:D009336), memory impairment (MESH:D008569), infectious (MESH:D003141), cognitive impairment (MESH:D003072), atherosclerosis (MESH:D050197), subarachnoid hemorrhage (MESH:D013345), hypertension (MESH:D006973), brain lesions (MESH:D001927), intracranial arterial stenoses (MESH:D012078), PACNS (MESH:C535276)
- **Chemicals:** methylprednisolone (MESH:D008775), methotrexate (MESH:D008727), cyclophosphamide (MESH:D003520), mycophenolate mofetil (MESH:D009173), C (MESH:D002244), prednisone (MESH:D011241), Steroids (MESH:D013256), gadolinium (MESH:D005682), alcohol (MESH:D000438), Ca (MESH:D002118), glucose (MESH:D005947), H&amp;E (MESH:D006371), dexamethasone (MESH:D003907)
- **Species:** Fungi (kingdom) [taxon 4751], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Enterovirus (genus) [taxon 12059], Human alphaherpesvirus 2 (no rank) [taxon 10310], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922086/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922086/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922086/full.md

---
Source: https://tomesphere.com/paper/PMC12922086